• Carbapenemase Gene Transmission in Enterobacter cloacae

  2026-09-09

  This multicenter study characterizes carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong during 2022–2024. Its combination of gene-localization, conjugation, mobile-element, antimicrobial-susceptibility, and genotyping analyses shows how plasmid-associated blaNDM-1 can support both horizontal transfer and persistence across clinical settings.

• HABA in Translational PLGA Delivery Research

  2026-09-09

  HABA can connect avidin-biotin surface chemistry with translational particle design by revealing functionally accessible binding sites. This thought-leadership analysis explains how 4-hydroxyazobenzene-2-carboxylic acid can complement particle characterization, release testing, and bioconjugate quality control in PLGA-based cartilage delivery research.

• Danazol C3644: Reliable Cell Assay Workflows

  2026-09-08

  This scenario-driven guide explains how Danazol (SKU C3644) can support interpretable cell viability, proliferation, and endocrine-modulation experiments. It covers mechanism, solvent compatibility, protocol controls, in vivo translation, and practical criteria for selecting a reliable research-grade material.

• Prestained Protein Marker: F4005 Lab Guide

  2026-09-08

  Learn how SKU F4005, the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa), supports reproducible SDS-PAGE, transfer assessment, and Western blot interpretation after viability, proliferation, or cytotoxicity assays. This scenario-based guide connects product specifications with practical experimental decisions and relevant protein-analysis evidence.

• Albiflorin Inhibits Renal Cell Carcinoma Signaling

  2026-09-07

  This reference study integrates cell-based assays, network pharmacology, molecular docking, and experimental validation to examine how albiflorin affects renal cell carcinoma (RCC). The findings associate reduced RCC viability, proliferation, and migration with suppression of EGFR/MAPK signaling and altered MMP9 and FGF2 expression, while also defining important limits for mechanistic interpretation.

• AO/PI Double Staining Kit: Practical Workflow

  2026-09-07

  The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that distinguishes viable, apoptotic, and necrotic cells using Acridine Orange and Propidium Iodide. It is appropriate for endpoint apoptosis detection and necrosis detection when fluorescence acquisition and cell-type-specific optimization are available, but not for nonfluorescent readouts or unvalidated continuous live-cell tracking.

• Biomimetic α-Cyperone Nanoparticles in KGN Inflammation

  2026-09-05

  The reference study develops PLGA@AC@FSHL-M nanoparticles that combine α-cyperone delivery, macrophage-membrane camouflage, and FSHL81–95 targeting in an LPS-stressed KGN granulosa-cell model. The findings connect reduced inflammatory cytokines and apoptosis with Nrf2/HO-1 activation, ROS suppression, and NF-κB inhibition, while remaining limited to in vitro evidence.

• TBST for Evidence-Grade Immunoassays

  2026-09-04

  TBST is more than a routine wash buffer: its detergent and salt chemistry can influence assay specificity, reproducibility, and interpretation. This guide connects TBST workflow decisions with orthogonal evidence from uPAR–uPA metastasis research.

• D-Luciferin Potassium Salt for Translational BLI

  2026-09-04

  D-Luciferin potassium salt supports water-based, reproducible firefly luciferase workflows spanning tumor cell tracking, reporter assays, ATP measurements, and longitudinal animal imaging. This guide connects practical substrate handling with the BCL6–ESM1 hepatocellular carcinoma study to help researchers separate tumor burden, reporter activity, and immune effects.

• Tetrazolium (chloride) for Viability Mapping

  2026-09-03

  Tetrazolium (chloride), also called Tetrazolium Red or TTC, converts mitochondrial dehydrogenase activity into a visible redox map of viable cells and tissue. This guide connects practical cell and ischemic-tissue workflows with the cardamomin stroke study, emphasizing controls, quantitative readouts, and troubleshooting.

• Sulfo-NHS-Biotin in Single-Cell Translation

  2026-09-03

  A mechanistic and strategic guide to using Sulfo-NHS-Biotin for surface-restricted protein labeling, affinity workflows, and emerging single-cell functional assays inspired by capped nanovial technology.

• 1-methyl Adenosine for Reliable Cell Assays

  2026-09-02

  Learn how 1-methyl Adenosine (SKU C5753) can support RNA modification research, cell-based mechanistic studies, and biomarker workflows without confusing nucleoside abundance with viability. This scenario-driven guide covers stock preparation, UHPLC–MS/MS quantification, interpretation, and practical product selection.

• NU6300 Targets Gasdermin D Cysteine-191

  2026-09-02

  Jiang et al. identify NU6300 as a covalent gasdermin D inhibitor that targets cysteine-191 and blocks both GSDMD cleavage and palmitoylation. The study connects this mechanism with reduced pyroptosis in cellular models and protection in dextran sodium sulfate–induced colitis and lipopolysaccharide-induced sepsis.

• PDE-5-Silenced BMSCs in Diabetic Cardiomyopathy

  2026-09-01

  The reference study shows that bone marrow mesenchymal stem cells with reduced PDE-5 activity can protect high-glucose-exposed cardiomyocytes and suppress fibrosis-associated responses through cGMP/PKG signaling. Its main innovation is the use of engineered BMSCs to modify a cardioprotective second-messenger pathway, although the findings remain primarily in vitro and require validation in more clinically representative models.

• PDHA1 Succinylation and α-KGA in Cholangiocarcinoma

  2026-09-01

  A 2025 Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic control point that increases α-ketoglutarate accumulation in the cholangiocarcinoma microenvironment. The resulting α-KGA–OXGR1–MAPK axis suppresses macrophage MHC-II antigen presentation, while pharmacological inhibition of succinylation improves gemcitabine–cisplatin responses in preclinical models.

817 records 8/55 page Previous Next First page 上5页 678910 下5页 Last page